W
Whitehawk Therapeutics, Inc. (WHWK)
NCM – Real vaqt narxi. Valyuta: USD
4.16
+0.05 (1.22%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.16
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.16
+0.05 (1.22%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
4.16
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
Whitehawk Therapeutics, Inc., bu saraton davridagi onkologiya terapiyasi kompaniyasi boʻlib, u saratonni davolash uchun oʻsmalarning biologiyasini oʻrganish texnologiyalarini ishlab chiqadi. U saratonni davolash uchun uchta keyingi avlod dori-darmon kon'yugatlarining (ADC) portfelini taqdim etadi. Kompaniya ilgari Aadi Bioscience, Inc. nomi bilan tanilgan va 2021-yil avgust oyida Whitehawk Therapeutics, Inc. nomini oʻzgartirgan. Whitehawk Therapeutics, Inc. 2007-yilda tashkil etilgan va Nyu-Jersi shtatining Morristown shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. David Dornan Ph.D. | Chief Scientific Officer |
| Dr. David J. Lennon Ph.D. | President, CEO & Director |
| Dr. Margaret Han Dugan M.D. | Chief Medical Officer |
| Dr. Neil P. Desai Ph.D. | Founder & Director |
| Mr. Bryan Ball | Chief Technical Operations Officer |
| Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications |
| Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-12 | 8-K | whwk-20260611.htm |
| 2026-05-29 | S-3 | d155546ds3.htm |
| 2026-05-21 | 8-K | d32951d8k.htm |
| 2026-05-13 | 8-K | d854431d8k.htm |
| 2026-05-07 | 8-K | whwk-20260507.htm |
| 2026-05-07 | 10-Q | whwk-20260331.htm |
| 2026-04-28 | DEFA14A | whwk-20260428.htm |
| 2026-04-28 | DEF 14A | whwk-20260428.htm |
| 2026-04-28 | ARS | whwk_-_2025_annual_repor.pdf |
| 2026-03-12 | S-8 | d82551ds8.htm |